Valiant Laboratories Limited (VALIANTLAB) Financial History

Name: Valiant Laboratories Limited (VALIANTLAB) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Valiant Laboratories Limited (VALIANTLAB) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 84 employees. Its market capitalization is roughly ₹7 billion. In the fiscal year ended 2026-03-31, VALIANTLAB reported ₹2.4B in revenue and (₹33M) in net income.

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally.

Interactive charts & full statements →

VALIANTLAB Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹2.4B	₹1.3B	₹1.8B	₹3.3B	—
Gross Profit	₹296M	₹106M	₹55M	₹492M	—
Operating Income (EBIT)	₹5M	(₹35M)	(₹104M)	₹336M	—
Net Income	(₹33M)	(₹22M)	₹3M	₹290M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VALIANTLAB Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2024-12-31
Total Revenue	₹1.2B	₹920M	₹525M	₹462M	₹468M	—
Gross Profit	₹475M	₹198M	₹75M	₹59M	₹71M	—
Operating Income (EBIT)	₹264M	₹19M	(₹29M)	(₹4M)	₹19M	—
Net Income	₹211M	₹18M	(₹71M)	₹2M	₹18M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VALIANTLAB Free Cash Flow History

VALIANTLAB Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹4.6B	₹4.0B	₹3.4B	₹2.1B	—
Total Liabilities	₹1.5B	₹1.7B	₹1.1B	₹1.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VALIANTLAB viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

APTX · Apotex Health Corp. — C$8 billion
BAFNAPH · Bafna Pharmaceuticals Limited — ₹8 billion
AMANTA · Amanta Healthcare Limited — ₹7 billion
ZIMLAB · ZIM Laboratories Limited — ₹7 billion
KILITCH · Kilitch Drugs (India) Limited — ₹7 billion
0460 · Sihuan Pharmaceutical Holdings Group Ltd. — HK$7 billion
6185 · CanSino Biologics Inc. — HK$7 billion
0570 · China Traditional Chinese Medicine Holdings Co. Limited — HK$6 billion

← VALG All “V” companies VALIANTORG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.